Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pelosi Senior Aide: Health Care Reform Could Be Reality By Easter

This article was originally published in The Gray Sheet

Executive Summary

A top aide for Speaker of the House Nancy Pelosi, D-Calif, expressed confidence Feb. 9 that health care reform could be signed into law by April

You may also be interested in...



Device Excise Tax Survives In Obama Health Reform Proposal

President Obama included a $20 billion excise tax on the device industry, similar to a provision passed by the House last November, in a health care reform proposal he issued in the lead-up to a Feb. 25 bipartisan summit

Device Excise Tax Survives In Obama Health Reform Proposal

President Obama included a $20 billion excise tax on the device industry, similar to a provision passed by the House last November, in a health care reform proposal he issued in the lead-up to a Feb. 25 bipartisan summit

Device Firms Stand To Lose Market Opportunities If Health Care Reform Dies

With the fate of comprehensive health care reform in serious doubt at the eleventh hour, many in the device industry may be breathing a sigh of relief that the device tax could be avoided or at least lessened. But if the reform bill dies, the industry will also lose out on the potential 30 million additional health care customers slated to gain insurance under its provisions

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT028502

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel